Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Avalo Therapeutics Inc.

    NASDAQ: AVTX · Real-Time Price · USD
    4.59
    -0.02 (-0.43%)
    At close: Jun 17, 2025, 1:42 PM

    Avalo Therapeutics Revenue

    Avalo Therapeutics reported an annual revenue of $441K, reflecting a -77.08% growth. For the quarter ending March 31, 2025, Avalo Therapeutics generated $0 in revenue.
    Revenue (ttm)
    $441K
    Revenue Growth
    -77.08%
    Price / Sales Ratio
    136.95
    Revenue / Employee
    $19.17K
    Employees
    23
    Market Cap
    49.7M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist